Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins

Frontiers in Neuroscience

Volumn 9, Issue JAN, 2015, Pages

  Dwivedi, Tushar ^a   Zhang, Hui ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Apoptotic regulatory genes; BDNF; Bipolar; Hippocampal culture; Lithium; Methylation

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CASPASE 3; GLUTAMIC ACID; LITHIUM; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN BAD; PROTEIN BAX; PROTEIN BCL 2; PROTEIN BCL XL;

ANIMAL CELL; ARTICLE; CELL STRUCTURE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; EXON; GENE EXPRESSION; NEUROPROTECTION; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; REGULATOR GENE;

EID: 84921718522     PISSN: 16624548     EISSN: 1662453X     Source Type: Journal    
DOI: 10.3389/fnins.2014.00457     Document Type: Article

References (49)

1. Aid, T., Kazantseva, A., Piirsoo, M., Palm, K., and Timmusk, T. (2007). Mouse and rat BDNF gene structure and expression revisited. J. Neurosci. Res. 85, 525-535. doi: 10.1002/jnr.21139
2. Brambilla, P., Glahn, D. C., Balestrieri, M., and Soares, J. C. (2005). Magnetic resonance findings in bipolar disorder. Psychiatr. Clin. North Am. 28, 443-467. doi: 10.1016/j.psc.2005.01.006
3. Chang, K., Karchemskiy, A., Barnea-Goraly, N., Garrett, A., Simeonova, D. I., and Reiss, A. (2005). Reduced amygdalar gray matter volume in familial pediatric bipolar disorder. J. Am. Acad. Child. Adolesc. Psychiatry 44, 565-573. doi: 10.1097/01.chi.0000159948.75136.0d
4. Chen, G., and Manji, H. K. (2006). The extracellular signal-regulated kinase pathway: an emerging promising target for mood stabilizers. Curr. Opin. Psychiatry 19, 313-323. doi: 10.1097/01.yco.0000218604.63463.cd
5. Cunha, A. B., Frey, B. N., Andreazza, A. C., Goi, J. D., Rosa, A. R., Gonçalves, C. A., et al. (2006). Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes. Neurosci. Lett. 398, 215-219. doi: 10.1016/j.neulet.2005.12.085
6. D'Addario, C., Dell'Osso, B., Palazzo, M. C., Benatti, B., Lietti, L., Cattaneo, E., et al. (2012). Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII. Neuropsychopharmacology 37, 1647-1655. doi: 10.1038/npp.2012.10
7. Drevets, W. C. (2001). Neuroimaging and neuropathological studies of depression: implications for the cognitive-emotional features of mood disorders. Curr. Opin. Neurobiol. 11, 240-249. doi: 10.1016/S0959-4388(00)00203-8
8. Engel, S. R., Creson, T. K., Hao, Y., Shen, Y., Maeng, S., Nekrasova, T., et al. (2009). The extracellular signal-regulated kinase pathway contributes to the control of behavioral excitement. Mol. Psychiatry. 14, 448-461. doi: 10.1038/sj.mp.4002135.
9. Fiorentino, A., Sharp, S. I., and McQuillin, A. (2014). Association of rare variation in the glutamate receptor gene SLC1A2 with susceptibility to bipolar disorder and schizophrenia. Eur. J. Hum. Genet. doi: 10.1038/ejhg.2014.261. [Epub ahead of print].
10. Fountoulakis, K. N. (2012). The possible involvement of NMDA glutamate receptor in the etiopathogenesis of bipolar disorder. Curr. Pharm. Des. 18, 1605-1608. doi: 10.2174/138161212799958585
11. Gao, Y., Galante, M., El-Mallakh, J., Nurnberger, J. I. Jr., Delamere, N. A., Lei, Z., et al. (2012). BDNF expression in lymphoblastoid cell lines carrying BDNF SNPs associated with bipolar disorder. Psychiatr. Genet. 22, 253-255. doi: 10.1097/YPG.0b013e328353ae66
12. Gigante, A. D., Young, L. T., Yatham, L. N., Andreazza, A. C., Nery, F. G., Grinberg, L. T., et al. (2011). Morphometric post-mortem studies in bipolar disorder: possible association with oxidative stress and apoptosis. Int. J. Neuropsychopharmacol. 14, 1075-1089. doi: 10.1017/S146114571000146X
13. Gildengers, A. G., Butters, M. A., Aizenstein, H. J., Marron, M. M., Emanuel, J., Anderson, S. J., et al. (2014). Longer lithium exposure is associated with better white matter integrity in older adults with bipolar disorder. Bipolar Disord. doi: 10.1111/bdi.12260. [Epub ahead of print].
14. Glitz, D. A., Manji, H. K., and Moore, G. J. (2002). Mood disorders: treatment-induced changes in brain neurochemistry and structure. Semin. Clin. Neuropsychiatry 7, 269-280. doi: 10.1053/scnp.2002.35226
15. Hashimoto, K., Sawa, A., and Iyo, M. (2007). Increased levels of glutamate in brains from patients with mood disorders. Biol. Psychiatry 62, 1310-1316. doi: 10.1016/j.biopsych.2007.03.017
16. Hassel, B., and Dingledine, R. (2006). "Glutamate," in Basic Neurochemistry: Molecular, Cellular, and Medical Aspects, eds G. J. Siegel, R. W. Albers, S. T. Brady, and D. L. Price (San Diego, CA: Academic Press), 267-290.
17. Hoekstra, R., Fekkes, D., Loonen, A., Pepplinkhuizen, L., Tuinier, S., and Verhoeven, W. (2006). Bipolar mania and plasma amino acids: increased levels of glycine. Eur. Neuropsychopharmacol. 16, 71-77. doi: 10.1016/j.euroneuro.2005.06.003
18. Hoshi, M., Sato, M., Matsumoto, S., Noguchi, A., Yasutake, K., Yoshida, N., et al. (2003). Spherical aggregates of beta-amyloid (amylospheroid) show high neurotoxicity and activate tau protein kinase I/glycogen synthase kinase-3beta. Proc. Natl. Acad. Sci. U.S.A. 100, 6370-6375. doi: 10.1073/pnas.1237107100
19. Huang, E. J., and Reichardt, L. F. (2001). Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677-736. doi: 10.1146/annurev.neuro.24.1.677
20. Itokawa, M., Yamada, K., Iwayama-Shigeno, Y., Ishitsuka, Y., Detera-Wadleigh, S., and Yoshikawa, T. (2003). Genetic analysis of a functional GRIN2A promoter (GT)n repeat in bipolar disorder pedigrees in humans. Neurosci. Lett. 345, 53-56. doi: 10.1016/S0304-3940(03)00501-9
21. Jornada, L. K., Moretti, M., Valvassori, S. S., Ferreira, C. L., Padilha, P. T., Arent, C. O., et al. (2010). Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. J. Psychiatr. Res. 44, 506-510. doi: 10.1016/j.jpsychires.2009.11.002
22. Kandaswamy, R., McQuillin, A., Curtis, D., and Gurling, H. (2014). Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder. Am. J. Med. Genet. B Neuropsychiatr. Genet. 165, 365-372. doi: 10.1002/ajmg.b.32239
23. Kapczinski, F., Frey, B. N., Kauer-Sant'Anna, M., and Grassi-Oliveira, R. (2008). Brain-derived neurotrophic factor and neuroplasticity in bipolar disorder. Expert Rev. Neurother. 8, 1101-1113. doi: 10.1586/14737175.8.7.1101
24. Karege, F., Perroud, N., Schürhoff, F., Méary, A., Marillier, G., Burkhardt, S., et al. (2010). Association of AKT1 gene variants and protein expression in both schizophrenia and bipolar disorder. Genes Brain Behav. 9, 503-511. doi: 10.1111/j.1601-183X.2010.00578.x
25. Lowthert, L., Leffert, J., Lin, A., Umlauf, S., Maloney, K., Muralidharan, A., et al. (2012). Increased ratio of anti-apoptotic to pro-apoptotic Bcl2 gene-family members in lithium-responders one month after treatment initiation. Biol. Mood Anxiety Disord. 2:15. doi: 10.1186/2045-5380-2-15
26. Lubin, F. D., Roth, T. L., and Sweatt, J. D. (2008). Epigenetic regulation of BDNF gene transcription in the consolidation of fear memory. J. Neurosci. 28, 10576-10586. doi: 10.1523/JNEUROSCI.1786-08.2008
27. Lucken-Ardjomande, S., and Martinou, J. C. (2005). Regulation of Bcl-2 proteins and of the permeability of the outer mitochondrial membrane. C. R. Biol. 328, 616-631. doi: 10.1016/j.crvi.2005.05.002
28. Magno, L. A., Miranda, D. M., Neves, F. S., Pimenta, G. J., Mello, M. P., De Marco, L. A., et al. (2010). Association between AKT1 but not AKTIP genetic variants and increased risk for suicidal behavior in bipolar patients. Genes Brain Behav. 9, 411-418. doi: 10.1111/j.1601-183X.2010.00571.x
29. McCullumsmith, R., Kristiansen, L., Beneyto, M., Scarr, E., Dean, B., and Meador-Woodruff, J. (2007). Decreased NR1, NR2A, and SAP102 transcript expression in the hippocampus in bipolar disorder. Brain Res. 1127, 108-118. doi: 10.1016/j.brainres.2006.09.011
30. Monteleone, P., Serritella, C., Martiadis, V., and Maj, M. (2008). Decreased levels of serum brain-derived neurotrophic factor in both depressed and euthymic patients with unipolar depression and in euthymic patients with bipolar I and II disorders. Bipolar Disord. 10, 95-100. doi: 10.1111/j.1399-5618.2008.00459.x
31. Moore, G. J., Bebchuk, J. M., Hasanat, K., Chen, G., Seraji-Bozorgzad, N., Wilds, I. B., et al. (2000b). Lithium increases N-acetyl-aspartate in the human brain: in vivo evidence in support of bcl-2's neurotrophic effects? Biol. Psychiatry 48, 1-8. doi: 10.1016/S0006-3223(00)00252-3
32. Moore, G. J., Bebchuk, J. M., Wilds, I. B., Chen, G., and Manji, H. K. (2000a). Lithium-induced increase in human brain grey matter. Lancet 356, 1241-1242. doi: 10.1016/S0140-6736(00)02793-8
33. Nock, M. K., Hwang, I., Sampson, N., Kessler, R. C., Angermeyer, M., Beautrais, A., et al. (2009). Cross-national analysis of the associations among mental disorders and suicidal behavior: findings from the WHO World Mental Health Surveys. PLoS Med 6:e1000123. doi: 10.1371/journal.pmed.1000123
34. Pompili, M., Innamorati, M., Gonda, X., Erbuto, D., Forte, A., Ricci, F., et al. (2013). Characterization of patients with mood disorders for their prevalent temperament and level of hopelessness. J. Affect Disord. 166, 285-291. doi: 10.1016/j.jad.2014.05.018
35. Rybakowski, J. K. (2011). Lithium in neuropsychiatry: a 2010 update. World J. Biol. Psychiatry 12, 340-348. doi: 10.3109/15622975.2011.559274
36. Sapolsky, R. M. (2000). Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders. Arch. Gen. Psychiatry 57, 925-935. doi: 10.1001/archpsyc.57.10.925
37. Savitz, J. B., Price, J. L., and Drevets, W. C. (2014). Neuropathological and neuromorphometric abnormalities in bipolar disorder: view from the medial prefrontal cortical network. Neurosci. Biobehav. Rev. 42C, 132-147. doi: 10.1016/j.neubiorev.2014.02.008
38. Schroeder, E., Gao, Y., Roberts, R. J., and El-Mallakh, R. S. (2011). Recognition and management of bipolar depression. J. Clin. Outcomes Manag. 18, 515-525.
39. Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., and Peter, M. E. (1998). Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459. doi: 10.1046/j.1432-1327.1998.2540439.x
40. Soeiro-de-Souza, M. G., Salvadore, G., Moreno, R. A., Otaduy, M. C., Chaim, K. T., Gattaz, W. F., et al. (2013). Bcl-2 rs956572 polymorphism is associated with increased anterior cingulate cortical glutamate in euthymic bipolar I disorder. Neuropsychopharmacology 38, 468-475. doi: 10.1038/npp.2012.203
41. Visnjic, D., and Banfic, H. (2007). Nuclear phospholipid signaling: phosphatidylinositol-specific phospholipase C and phosphoinositide 3-kinase. Pflugers Arch. 455, 19-30. doi: 10.1007/s00424-007-0288-1
42. Watson, S., Gallagher, P., Ritchie, J., Ferrier, I., and Young, A. (2004). Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br. J. Psychiatry 184, 496-502. doi: 10.1192/bjp.184.6.496
43. Wilson, B. E., Mochon, E., and Boxer, L. M. (1996). Induction of bcl-2 expression by phosphorylated CREB proteins during B-cell activation and rescue from apoptosis. Mol. Cell Biol. 16, 5546-5556.
44. Wu, R., Fan, J., Zhao, J., Calabrese, J. R., and Gao, K. (2014). The relationship between neurotrophins and bipolar disorder. Expert Rev. Neurother. 14, 51-65. doi: 10.1586/14737175.2014.863709
45. Yildiz-Yesiloglu, A., and Ankerst, D. P. (2006). Review of 1H magnetic resonance spectroscopy findings in major depressive disorder: a meta-analysis. Psychiatry Res. 147, 1-25. doi: 10.1016/j.pscychresns.2005.12.004
46. Young, W. (2009). Review of lithium effects on brain and blood. Cell Transplant. 18, 951-975. doi: 10.3727/096368909X471251
47. Yuan, J., and Yankner, B. A. (2000). Apoptosis in the nervous system. Nature 407, 02-809. doi: 10.1038/35037739
48. Zarate, C. J., Singh, J., and Manji, H. (2006). Cellular plasticity cascades: targets for the development of novel therapeutics for bipolar disorder. Biol. Psychiatry 59, 1006-1020. doi: 10.1016/j.biopsych.2005.10.021
49. Zhou, R., Gray, N. A., Yuan, P., Li, X., Chen, J., Chen, G., et al. (2005). The anti-apoptotic, glucocorticoid receptor cochaperone protein BAG-1 is a long-term target for the actions of mood stabilizers. J. Neurosci. 25, 4493-4502. doi: 10.1523/JNEUROSCI.4530-04.2005